Cellular responses to ionizing radiation (IR)-induced DNA double strand breaks (DSBs) involve activation, via the phosphatidylinositol 3-kinase-like kinase (PIKK) ATM, of cell cycle checkpoint proteins that delay cell cycle progression to allow DNA repair and to preserve chromosomal integrity. Responses to DNA DSBs induced by the radiomimetic enediyne C-1027 deviate from this model. For example, IR induces ATM-dependent, and C-1027, both ATM- dependent and independent, responses. Furthermore, treatment with equi-cytotoxic levels of IR or C-1027 results in either a very low (2.9%), or an extraordinarily high (92%), percentage, respectively of mitotic cells showing aberrant chromosomal recombination. FISH analysis revealed that C-1027-induced chromosomal aberrations are frequently associated with disruption of telomeres. The mechanism(s) behind these unique responses to the antitumor drug, C-1027 should help extend our understanding of DNA damage responses to DSBs. First, pivotal checkpoint pathway proteins involved in the response to C-1027 will be identified, with emphasis on both ATM-dependent and independent responses. Next the conditions under which C-1027 induces extensive chromosomal fusions, characterized by aberrant end-joining and fragmentation, will be identified. The NHEJ DNA binding protein Ku, which not only is involved in repair responses but also plays a role in regulating chromosomal fusions, will also be examined for its role in C-1027 induced aberrant end-joining. Finally, we will test whether C-1027, which induces DSBs preferentially within a GTTA motif, targets the telomere tandem repeat sequence (GGGTTA) and contributes to aberrant end-joining by inducing telomere dysfunction. Other enediynes with cleavage characteristics different from C-1027, will be tested selectively to provide additional mechanistic insights into which properties of C-1027-induced damage are associated with the DNA damage responses.
The specific aims will test the following hypotheses: 1. C-1027 is unique compared to other enediynes and to IR in that it induces both ATM-dependent and independent DNA damage responses. 2. C-1027 is unique compared to other enediynes and to IR in that it causes extraordinarily high levels of rearranged chromosomes. 3. C-1027 is unique compared to other enediynes and IR in that it targets telomeres.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA106312-03
Application #
7169561
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Arya, Suresh
Project Start
2005-02-14
Project End
2009-01-31
Budget Start
2007-02-01
Budget End
2008-01-31
Support Year
3
Fiscal Year
2007
Total Cost
$272,793
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Beerman, Terry A; Gawron, Loretta S; Shen, Ben et al. (2014) The radiomimetic enediyne, 20'-deschloro-C-1027 induces inter-strand DNA crosslinks in hypoxic cells and overcomes cytotoxic radioresistance. DNA Repair (Amst) 21:165-70
San Pedro, Joanna Maria N; Beerman, Terry A; Greenberg, Marc M (2012) DNA damage by C1027 involves hydrogen atom abstraction and addition to nucleobases. Bioorg Med Chem 20:4744-50
McHugh, Mary; Beerman, Terry (2009) An extraction-free method by which a single slot blot can be used to quantify intracellular DNA damage (crosslinks or strand breaks) and changes in DNA damage response proteins or replication. Biotechniques 46:127-9
Beerman, Terry A; Gawron, Loretta S; Shin, Seulkih et al. (2009) C-1027, a radiomimetic enediyne anticancer drug, preferentially targets hypoxic cells. Cancer Res 69:593-8
Kennedy, Daniel R; Ju, Jianhua; Shen, Ben et al. (2007) Designer enediynes generate DNA breaks, interstrand cross-links, or both, with concomitant changes in the regulation of DNA damage responses. Proc Natl Acad Sci U S A 104:17632-7
Kennedy, Daniel R; Gawron, Loretta S; Ju, Jianhua et al. (2007) Single chemical modifications of the C-1027 enediyne core, a radiomimetic antitumor drug, affect both drug potency and the role of ataxia-telangiectasia mutated in cellular responses to DNA double-strand breaks. Cancer Res 67:773-81
Mallakin, A; Taneja, P; Matise, L A et al. (2006) Expression of Dmp1 in specific differentiated, nonproliferating cells and its regulation by E2Fs. Oncogene 25:7703-13
Kennedy, Daniel R; Beerman, Terry A (2006) The radiomimetic enediyne C-1027 induces unusual DNA damage responses to double-strand breaks. Biochemistry 45:3747-54
McHugh, Mary M; Gawron, Loretta S; Matsui, Sei-Ichi et al. (2005) The antitumor enediyne C-1027 alters cell cycle progression and induces chromosomal aberrations and telomere dysfunction. Cancer Res 65:5344-51